Part:BBa_K4308001
Reverse Primer for RPA of LINC00857
Long intergenic non-protein coding RNA 857 (LINC00857) is a genetic molecule involved in cancer biology, which is identified as one of the most upregulated LINCRNAs in lung cancer. It could lead to resistance to platinum‐induced apoptosis by affecting mRNA stability or promoting its translation. Thus, we chose LINC00857 as a novel prognostic and cancer predictive biomarker. We use this part as the reverse primer to conduct reverse transcription-recombinase polymerase amplification (RT-RPA) of LINC00857, along with its forward primer (BBa_K4308000).
Usage and Biology
In our project, this primer (BBa_K4308001) was used along with its forward primer (BBa_K4308000) for the amplification reactions of LINC00857, in order to perform isothermal amplification reactions with RT-RPA. Using this method, we were able to detect quantities as low as 10-9 nanograms during 30 minutes. The expected amplified product length is about 150 bp.
Characterization
1.Proof of the expression
After RT-RPA amplification, we carried out 3% agarose gel electrophoresis to verify the amplification results. As can be seen in Figure 1, compared with negative control, our product has obvious bands, which also confirms the validity of the primer.
Figure.1 3% agarose gel electrophoresis to verify the amplification. Lane 1: Target gene (10 nM, centrifuged); Lane 2 : Target gene (1 nM, centrifuged); Lane 3 : Target gene (10 nM, uncentrifuged); Lane 4 : Target gene (1 nM, uncentrifuged).
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
| None |